Effects of acetylcholinesterase inhibitors on sleep architecture in Alzheimer's disease patients

被引：0
|
作者：
Loredo, JS
Linn, M
Liu, L
Greenfield, D
Marler, M
Corey-Bloom, J
Ancoli-Israel, S
机构：
[1] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Vet Affairs San Diego Healthcare Syst, Dept Psychiat, La Jolla, CA 92093 USA
[3] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA
来源：
SLEEP | 2003年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A349 / A349
页数：1
相关论文
共 50 条
  • [21] Progress in acetylcholinesterase inhibitors for Alzheimer's disease: an update
    Tumiattit, Vincenzo
    Bolognesi, Maria Laura
    Minarini, Anna
    Rosini, Michela
    Milelli, Andrea
    Matera, Riccardo
    Melchiorre, Carlo
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2008, 18 (04) : 387 - 401
  • [22] Target Enzyme in Alzheimer's Disease: Acetylcholinesterase Inhibitors
    Saxena, Mridula
    Dubey, Ragini
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2019, 19 (04) : 264 - 275
  • [23] Acetylcholinesterase inhibitors and nanoparticles on Alzheimer’s disease: a review
    Sara Silva
    António J. Almeida
    Nuno Vale
    Journal of Nanoparticle Research, 2021, 23
  • [24] Effects of acetylcholinesterase inhibitors and memantine on resting-state electroencephalographic rhythms in Alzheimer's disease patients
    Babiloni, Claudio
    Del Percio, Claudio
    Bordet, Regis
    Bourriez, Jean-Luis
    Bentivoglio, Marina
    Payoux, Pierre
    Derambure, Philippe
    Dix, Sophie
    Infarinato, Francesco
    Lizio, Roberta
    Triggiani, Antonio Ivano
    Richardson, Jill C.
    Rossini, Paolo M.
    CLINICAL NEUROPHYSIOLOGY, 2013, 124 (05) : 837 - 850
  • [25] Cardiovascular Complications of Acetylcholinesterase Inhibitors in Patients with Alzheimer's Disease: A Narrative Review
    Young, Sara
    Chung, Enoch
    Chen, Michael A.
    ANNALS OF GERIATRIC MEDICINE AND RESEARCH, 2021, 25 (03): : 170 - 177
  • [26] Acetylcholinesterase inhibitors and depressive symptoms in patients with mild to moderate Alzheimer's Disease
    Rozzini, Luca
    Chilovi, Barbara Vicini
    Bertoletti, Erik
    Trabucchi, Marco
    Padovani, Alessandro
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2007, 19 (03) : 220 - 223
  • [27] Acetylcholinesterase inhibitors and depressive symptoms in patients with mild to moderate Alzheimer's Disease
    Rozzini L.
    Chilovi B.V.
    Bertoletti E.
    Trabucchi M.
    Padovani A.
    Aging Clinical and Experimental Research, 2007, 19 (3) : 220 - 223
  • [28] Acetylcholinesterase Inhibitors as Disease-Modifying Therapies for Alzheimer's Disease
    Munoz-Torrero, D.
    CURRENT MEDICINAL CHEMISTRY, 2008, 15 (24) : 2433 - 2455
  • [29] Mechanisms of neuroprotective effects of therapeutic acetylcholinesterase inhibitors used in treatment of Alzheimer's disease
    Takatori, Yuki
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2006, 126 (08): : 607 - 616
  • [30] Discontinuation of acetylcholinesterase-inhibitors in Alzheimer's disease and its effects on cognitive functioning
    Steiger-Baechler, G
    Monsch, AU
    Bertoli, S
    Staehelin, HB
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S94 - S94
12345